Press — Updates & Announcements — Omega Funds

Updates &
Announcements

View all press

June 16, 2021

Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech? – The Boston Globe

Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech? – The Boston Globe

June 4, 2021

Biopharma and Venture Capital: A Deep Dive – Evaluate Vantage

Biopharma and Venture Capital: A Deep Dive – Evaluate Vantage

May 4, 2021

Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021

Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021

April 28, 2021

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

April 26, 2021

Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast

Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast

February 12, 2021

2021: The Rise of the Variants – TimmermanReport.com

2021: The Rise of the Variants – TimmermanReport.com

January 14, 2021

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

January 7, 2021

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

January 7, 2021

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies

LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies

January 7, 2021

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease

Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease

January 6, 2021

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

Omega Funds

16 Jun 2021

Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech? – The Boston Globe

The Boston Globe

Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech? – The Boston Globe

Omega Funds

4 Jun 2021

Biopharma and Venture Capital: A Deep Dive – Evaluate Vantage

Evaluate Vantage

Biopharma and Venture Capital: A Deep Dive – Evaluate Vantage

Omega Funds

4 May 2021

Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021

BIO Deutschland

Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021

Omega Funds

28 Apr 2021

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

Morphic Therapeutic

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors

Omega Funds

26 Apr 2021

Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast

RBC Capital Markets

Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast

Omega Funds

12 Feb 2021

2021: The Rise of the Variants – TimmermanReport.com

The Timmerman Report

2021: The Rise of the Variants – TimmermanReport.com

Omega Funds

14 Jan 2021

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

Wall Street Journal

Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal

Omega Funds

7 Jan 2021

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing

Scorpion Therapeutics

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing